Ki Nam Yong, Park Eun-Ji, Sung In sung, Ju Seul A, Kim Kyoung Un, Kim Mi Rae, Song Do Yeon, Lee Min-Ju, Kim Hak-Soo, Kang Boo-Hyon, Chung Hun-Jong, Choi Eun-Ju, Yoon Ki-Hun, Lee Min Won, Yun Seongho, Min Bokkee, Kwon Suk Hyung, Shin Hwa-Sup
Department of Biomedical Chemistry, College of Biomedical and Health Sciences, Konkuk University, Chungju, 27478, Korea.
Chemon Non-clinical Research Institute, Yangji, 17162, Korea.
Phytother Res. 2016 Apr;30(4):636-45. doi: 10.1002/ptr.5573. Epub 2016 Feb 3.
Smilacis Chinae Rhizome (SCR) has been used as an oriental folk medicine for various biological activities. However, its effect on atopic dermatitis (AD) remains undetermined to date. We assessed the effect of orally administered hot-water extract of SCR on AD-like skin lesions in mice and its underlying mechanisms. AD-like murine model was prepared by repeated alternate application of house dust mite (Dermatophagoides farinae) extract (DFE) and 2,4-dinitrochlorobenzene (DNCB) for 4 weeks, topically to the ears. Daily oral administration of SCR for 3 and 4 weeks significantly reduced inflammatory ear thickening, with the effect being enhanced at the earlier start and longer period of administration. This effect was accompanied by a significant decrease in both Th2 and Th1 serum antibodies (total IgE, DFE-specific IgE, and IgG2a). Histological analysis showed that SCR markedly decreased the epidermal/dermal ear thickening and the dermal infiltration of inflammatory cells. Furthermore, SCR suppressed DFE/DNCB-induced expression of IL-4, IL-13, IL-17, IL-18, TSLP, and IFN-γ genes in the ear tissue. Taken together, our observations demonstrate that chronic oral administration of SCR exerts beneficial effect in mouse AD model, suggesting that SCR has the therapeutic potential as an orally active treatment of AD by modulating both Th1 and Th2 responses.
菝葜根茎(SCR)作为一种东方民间药物,具有多种生物活性。然而,其对特应性皮炎(AD)的作用至今仍未明确。我们评估了口服SCR热水提取物对小鼠AD样皮肤损伤的影响及其潜在机制。通过在小鼠耳部反复交替涂抹屋尘螨(粉尘螨)提取物(DFE)和2,4-二硝基氯苯(DNCB)4周来制备AD样小鼠模型。连续3周和4周每日口服SCR可显著减轻耳部炎症性增厚,早期开始给药且给药时间更长时效果增强。这种效果伴随着Th2和Th1血清抗体(总IgE、DFE特异性IgE和IgG2a)的显著降低。组织学分析表明,SCR显著降低了耳部表皮/真皮增厚以及炎症细胞的真皮浸润。此外,SCR抑制了耳部组织中DFE/DNCB诱导的IL-4、IL-13、IL-17、IL-18、TSLP和IFN-γ基因的表达。综上所述,我们的观察结果表明,长期口服SCR对小鼠AD模型具有有益作用,提示SCR通过调节Th1和Th2反应,具有作为AD口服活性治疗药物的潜力。